Given that MAM modulates glutamate-stimulated neuronal tau mRNA expression in vitro[67], we have proposed elsewhere that continuous MAM activation of glutamate-stimulated tau expression could trigger a slowly progressive neurodegenerative disease (tauopathy) of the type seen in Western Pacific ALS-PDC [68]. The gene discussed is MAPT; the disease is tauopathy.